Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- Medical Oncology and Hematology Associates-West Des Moines
Clive, Iowa, United States
- Mercy Cancer Center-West Lakes
Clive, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa Oncology Research Association Ccop
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Mercy Medical Center-West Lakes
West Des Moines, Iowa, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Saint Luke'S South Hospital
Overland Park, Kansas, United States
- Shawnee Mission Medical Center
Shawnee Mission, Kansas, United States
- Franklin Square Hospital Center
Baltimore, Maryland, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
- University of Massachusetts Memorial Health Care
Worcester, Massachusetts, United States
- Michigan Cancer Research Consortium Community Clinical Oncology Program
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Oakwood Hospital
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Green Bay Oncology - Escanaba
Escanaba, Michigan, United States
- Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Green Bay Oncology - Iron Mountain
Iron Mountain, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Sparrow Hospital
Lansing, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
- Saint Joseph Mercy Port Huron
Port Huron, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 31 Jul 2012
- Completion
- 29 Jul 2012
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 29
- Registry id
- NCT00993616
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.